Purslane protects against the reproductive toxicity of carbamazepine treatment in pilocarpine-induced epilepsy model

被引:1
|
作者
Widad Makhdour Al-Bishri [1 ]
Eman Salah Abdel-Reheim [2 ]
Amr Reda Zaki [3 ]
机构
[1] Biochemistry Department,Faculty of Science,Al Faisaliah Campus,King Abdulaziz University
[2] Department of Zoology,Faculty of Science,Beni-Suef University
[3] Department of Forensic Medicine and Clinical Toxicology,Faculty of Medicine,Beni-Suef University
关键词
Pilocarpine; Purslane; Carbamazepine; Epilepsy; Fertility hormones;
D O I
暂无
中图分类号
R-332 [医用实验动物学]; R742.1 [癫痫];
学科分类号
1001 ; 1002 ;
摘要
Objective: To investigate the protective effect of purslane with carbamazepine treatment.Methods: Male albino rats were modulated by pilocarpine to be epileptic.Both the normal and epileptic rats were treated with carbamazepine, purslane or carbamazepine plus purslane, with separate non-treated control groups for both normal and epileptic rats.Results: The data from the current study showed amelioration in amino acids and electrolytes in the epileptic rats treated with purslane and carbamazepine, with this amelioration occurring without decreasing the fertility hormones(testosterone,dehydroepiandrosterone, luteinizing hormone and follicle stimulating hormone).Purslane treatments also prevented the increase in estradiol.The decreased epileptic hyperexcitability with purslane was evidenced by decreased glial fibrillary acidic protein and lipid peroxidation.Conclusions: Natural products like purslane could be used with the highly repetitive drugs like carbamazepine to reduce or prevent its side-effects.
引用
收藏
页码:339 / 346
页数:8
相关论文
共 50 条
  • [21] Mild hypothermia pretreatment protects against pilocarpine-induced status epilepticus and neuronalapoptosis in immature rats
    Yu, Lifei
    Zhou, Yuanfeng
    Chen, Wen
    Wang, Yi
    NEUROPATHOLOGY, 2011, 31 (02) : 144 - 151
  • [22] Effect on epileptogenesis of carbamazepine treatment during the silent period of the pilocarpine model of epilepsy
    Capella, HM
    Lemos, T
    EPILEPSIA, 2002, 43 : 110 - 111
  • [23] Drug resistance and hippocampal damage after delayed treatment of pilocarpine-induced epilepsy in the rat
    Chakir, A.
    Fabene, P. F.
    Ouazzani, R.
    Bentivoglio, M.
    BRAIN RESEARCH BULLETIN, 2006, 71 (1-3) : 127 - 138
  • [24] ACTH - A STRUCTURE-ACTIVITY STUDY ON PILOCARPINE-INDUCED EPILEPSY
    CROISET, G
    DEWIED, D
    EUROPEAN JOURNAL OF PHARMACOLOGY, 1992, 229 (2-3) : 211 - 216
  • [25] Estrogen effects on pilocarpine-induced temporal lobe epilepsy in rats
    Pereira, Melquiades, Jr.
    Soares, Jose M., Jr.
    Valente, Sandra G.
    Oliveira, Patricia B.
    Cavalheiro, Esper A.
    Amado, Dbora
    Baracat, Edmund C.
    MATURITAS, 2009, 62 (02) : 190 - 196
  • [26] MK-801 augments pilocarpine-induced electrographic seizure but protects against brain damage in rats
    Lee, MG
    Chou, JY
    Lee, KH
    Choi, BJ
    Kim, SK
    Kim, CY
    PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1997, 21 (02): : 331 - 344
  • [27] Abnormal Expression of FBXL20 in Refractory Epilepsy Patients and a Pilocarpine-Induced Rat Model
    Fu, Pengfei
    Wen, YueTao
    Xiong, Yan
    Zhang, Yanke
    Zhang, Haiyang
    Xie, Yanfeng
    Shi, Quanhong
    NEUROCHEMICAL RESEARCH, 2016, 41 (11) : 3020 - 3031
  • [28] Abnormal Expression of FBXL20 in Refractory Epilepsy Patients and a Pilocarpine-Induced Rat Model
    Pengfei Fu
    YueTao Wen
    Yan Xiong
    Yanke Zhang
    Haiyang Zhang
    Yanfeng Xie
    Quanhong Shi
    Neurochemical Research, 2016, 41 : 3020 - 3031
  • [29] Manganese-enhanced magnetic resonance imaging in the acute phase of the pilocarpine-induced model of epilepsy
    Malheiros, Jackeline Moraes
    Longo, Beatriz Monteiro
    Tannus, Alberto
    Covolan, Luciene
    EINSTEIN-SAO PAULO, 2012, 10 (02): : 247 - 252
  • [30] Alterations of functional connectivity in pilocarpine-induced mouse model of temporal lobe epilepsy in latent period
    Lee, Hyoin
    Jeong, Yong
    Jung, Seungmoon
    Lee, Jaehyun
    INTERNATIONAL JOURNAL OF NEUROPSYCHOPHARMACOLOGY, 2016, 19 : 268 - 268